Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Comparison of Hospitalization Costs Associated With Human Metapneumovirus and Respiratory Syncytial Virus Infection in US Adults.
Journal: Open forum infectious diseases
Published: December 29, 2025
Comparison of Healthcare Resource Utilization and Disease Outcomes in Adults Hospitalized with Human Metapneumovirus and Respiratory Syncytial Virus.
Journal: The Journal of infectious diseases
Published: September 03, 2025
Evaluating the Impact of Age and Comorbidities on COVID-19 Outcomes and Healthcare Costs: A Comparative Analysis of Immunocompromised and General Populations in the United States (EON-US).
Journal: Infectious diseases and therapy
Published: January 30, 2025
Drug product development and case studies for patient centric pediatric protein-based therapeutics.
Journal: Journal of pharmaceutical sciences
Published: May 14, 2024
Assessing the Burden and Cost of COVID-19 Across Variants in Commercially Insured Immunocompromised Populations in the United States: Updated Results and Trends from the Ongoing EPOCH-US Study.
Journal: Advances in therapy
Published: September 21, 2023
Assessing the risk and costs of COVID-19 in immunocompromised populations in a large United States commercial insurance health plan: the EPOCH-US Study.
Journal: Current medical research and opinion
Published: July 11, 2023
Factors influencing series completion rates of recombinant herpes zoster vaccine in the United States: A retrospective pharmacy and medical claims analysis.
Journal: Journal of the American Pharmacists Association : JAPhA
Published: September 03, 2021
Safety and reactogenicity of the adjuvanted recombinant zoster vaccine: experience from clinical trials and post-marketing surveillance.
Journal: Therapeutic advances in vaccines and immunotherapy
Published: May 12, 2021
Early examination of real-world uptake and second-dose completion of recombinant zoster vaccine in the United States from October 2017 to September 2019.
Journal: Human vaccines & immunotherapeutics
Published: April 14, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026